EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy

Sang Eun Yoon

Blood Research · 2026-12 · 61 (1)

DOI: 10.1007/s44313-026-00143-4 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Blood Research, online erschienen am 19.05.2026. Verfasst von Sang Eun Yoon. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-Gu, …. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-Gu, Seoul, 06351, Republic of Korea. starload0326@gmail.com.

Zitieren

APA

Yoon, S. E. (2026). A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy. Blood Research, 61(1). https://doi.org/10.1007/s44313-026-00143-4

Vancouver

Yoon SE. A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy. Blood Research. 2026;61(1). doi:10.1007/s44313-026-00143-4

BibTeX
@article{Yoon2026,
  author = {Yoon, Sang Eun},
  title = {A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy},
  journal = {Blood Research},
  year = {2026},
  volume = {61},
  number = {1},
  doi = {10.1007/s44313-026-00143-4}
}
Kostenlos starten →